MARGUGLIO DAVID J. (Sr VP of Business Development) sold 10.9% of their position (35K shares) of DMK PHARMACEUTICALS CORP on the open market
Open‑market sale worth $14.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/24/2020ACC: 0001593968-20-002246
DirectorOfficer· Sr VP of Business Development
Since Jan 2019
-35K
Net shares
Net seller
$14.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
35K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−35K
Price / share
$0.40
Trade value
$14K
% of position
10.9%
11/20/2020
322.26K→287.26K
Total
Net shares
−35K
Net value
-$14K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/20/2020 | S · Sale | −35K | $0.40 | $14K | 10.9% | 322.26K | 287.26K |
| Total | −35K | -$14K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned5.88K
Total
5.88K indirect5.88K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 5.88K | Indirect |
| Total | 5.88K | 5.88K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported